Cyclo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	0.93	9.25	1.54	16.61	12.85	2.78
Cash & Short-Term Investments	0.93	9.25	1.54	16.61	12.85	2.78
Cash Growth	-48.50%	499.10%	-90.71%	29.32%	361.47%	25.54%
Accounts Receivable	0.19	0.12	0.05	0.49	0.07	0.14
Receivables	0.19	0.12	0.05	0.54	0.11	0.18
Inventory	0.24	0.25	0.25	0.23	0.24	0.24
Prepaid Expenses	0.18	2.69	2.31	2.06	0.85	0.75
Other Current Assets	1.73	-	-	-	-	-
Total Current Assets	3.26	12.32	4.16	19.44	14.05	3.96
Property, Plant & Equipment	0.05	0.93	0.06	0.08	0.09	0.06
Long-Term Deferred Charges	1.95	-	-	-	-	-
Total Assets	5.25	13.25	4.22	19.52	14.19	4.11
Accounts Payable	5.02	4.86	2.23	3.68	3.54	3.12
Accrued Expenses	1.25	1.68	0.97	-	-	-
Short-Term Debt	12.18	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	0.13	0.11	-
Current Portion of Leases	0.02	1.01	-	0.02	0.02	0.02
Other Current Liabilities	0.25	0.92	0.27	-	-	-
Total Current Liabilities	18.72	8.47	3.48	3.83	3.67	3.14
Long-Term Debt	-	-	-	0.02	0.04	-
Long-Term Leases	0.01	0.02	-	-	0.02	0.04
Total Liabilities	18.73	8.49	3.48	3.85	3.74	3.18
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	89.54	88.61	64.53	64.02	44.51	26.06
Retained Earnings	-103.01	-83.86	-63.8	-48.35	-34.06	-25.12
Total Common Equity	-13.47	4.76	0.73	15.67	10.45	0.94
Shareholders' Equity	-13.47	4.76	0.73	15.67	10.45	0.94
Total Liabilities & Equity	5.25	13.25	4.22	19.52	14.19	4.11
Total Debt	12.21	1.03	-	0.17	0.19	0.05
Net Cash (Debt)	-11.28	8.21	1.54	16.44	12.65	2.73
Net Cash Growth	-	432.16%	-90.61%	29.96%	363.23%	23.17%
Net Cash Per Share	-0.42	0.50	0.18	2.58	7.91	2.52
Filing Date Shares Outstanding	28.77	28.72	10.55	8.41	6.29	1.22
Total Common Shares Outstanding	28.77	28.56	8.48	8.4	4.77	1.22
Working Capital	-15.46	3.85	0.68	15.61	10.38	0.82
Book Value Per Share	-0.47	0.17	0.09	1.86	2.19	0.77
Tangible Book Value	-13.47	4.76	0.73	15.67	10.45	0.94
Tangible Book Value Per Share	-0.47	0.17	0.09	1.86	2.19	0.77
Machinery	-	0.16	0.16	0.14	0.12	0.07

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q